Clinical Trial Update: CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction [NA]

View source ↗

Summary

Clinical trial update on the CORolla TAA device for heart failure with preserved ejection fraction and diastolic dysfunction; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Diastolic Dysfunction
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• CORolla TAA

Snippet

Sponsor: CorAssist Cadiovascular Ltd. | Conditions: Diastolic Heart Failure NYHA Class III-IV, Diastolic Dysfunction Secondary to Aortic Stenosis | NA | Status: UNKNOWN